Global Gastrointestinal Market Growth (Status and Outlook) 2025-2031

Global Gastrointestinal Market Growth (Status and Outlook) 2025-2031

The global Gastrointestinal market size is predicted to grow from US$ 36260 million in 2025 to US$ 44370 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

LPI (LP Information)' newest research report, the “Gastrointestinal Industry Forecast” looks at past sales and reviews total world Gastrointestinal sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastrointestinal sales for 2025 through 2031. With Gastrointestinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal industry.

This Insight Report provides a comprehensive analysis of the global Gastrointestinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastrointestinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key players and key regions and countries.

Segmentation by Type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segmentation by Application:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Please note: The report will take approximately 2 business days to prepare and deliver.